A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

In today's fast-paced world, respiratory health is often neglected, especially for those suffering from chronic conditions ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Human Metapneumovirus (HMPV) is a common respiratory disease among children and the elderly. Here's what we know about the ...

The 'mystery virus' sparked emergency measures in China after spikes in the northern provinces before it was identified as ...

A hacking cough is the primary symptom of bronchitis, according to the NHS. “A distinguishing feature of a bronchitis-related ...

The 5th edition of Manipal Hospital Old Airport Road’s flagship workshop series, Handling Unexpected Emergencies (HUE), ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

In February this year, the central government will launch free health screenings, considered one of the flagship health ...